Alicja Chrzanowska

954 total citations
39 papers, 726 citations indexed

About

Alicja Chrzanowska is a scholar working on Molecular Biology, Cancer Research and Biochemistry. According to data from OpenAlex, Alicja Chrzanowska has authored 39 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Cancer Research and 12 papers in Biochemistry. Recurrent topics in Alicja Chrzanowska's work include Amino Acid Enzymes and Metabolism (11 papers), Metabolism and Genetic Disorders (9 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Alicja Chrzanowska is often cited by papers focused on Amino Acid Enzymes and Metabolism (11 papers), Metabolism and Genetic Disorders (9 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Alicja Chrzanowska collaborates with scholars based in Poland and Italy. Alicja Chrzanowska's co-authors include Wioletta Olejarz, Grażyna Kubiak-Tomaszewska, Tomasz Lorenc, Anna Barańczyk‐Kuźma, Magdalena Mielczarek‐Puta, Marta Struga, Anna Bielenica, Piotr Roszkowski, Zofia Porembska and Karolina Stępień and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Alicja Chrzanowska

38 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alicja Chrzanowska Poland 14 404 202 107 97 81 39 726
Anil Kumar Badana India 12 591 1.5× 268 1.3× 114 1.1× 66 0.7× 90 1.1× 15 998
Lokesh Dalasanur Nagaprashantha United States 15 581 1.4× 115 0.6× 164 1.5× 62 0.6× 52 0.6× 23 961
Weon Young Chang South Korea 18 629 1.6× 129 0.6× 145 1.4× 53 0.5× 53 0.7× 31 974
Sumit J. Shah United States 15 448 1.1× 139 0.7× 130 1.2× 136 1.4× 117 1.4× 23 872
Caifeng Xie China 20 521 1.3× 205 1.0× 135 1.3× 181 1.9× 185 2.3× 42 980
Aamer Qazi United States 19 521 1.3× 192 1.0× 146 1.4× 70 0.7× 53 0.7× 31 1000
Qiangrong Pan China 13 689 1.7× 193 1.0× 203 1.9× 119 1.2× 74 0.9× 16 967
Hongqin Zhuang China 17 521 1.3× 127 0.6× 99 0.9× 42 0.4× 94 1.2× 46 814
Weiqiang Chen China 15 366 0.9× 202 1.0× 133 1.2× 54 0.6× 44 0.5× 37 842

Countries citing papers authored by Alicja Chrzanowska

Since Specialization
Citations

This map shows the geographic impact of Alicja Chrzanowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicja Chrzanowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicja Chrzanowska more than expected).

Fields of papers citing papers by Alicja Chrzanowska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alicja Chrzanowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicja Chrzanowska. The network helps show where Alicja Chrzanowska may publish in the future.

Co-authorship network of co-authors of Alicja Chrzanowska

This figure shows the co-authorship network connecting the top 25 collaborators of Alicja Chrzanowska. A scholar is included among the top collaborators of Alicja Chrzanowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicja Chrzanowska. Alicja Chrzanowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bielenica, Anna, Piotr Roszkowski, Joanna Stefańska, et al.. (2025). Antimicrobial profile of new pyrazole-based alkanoyl and oxoalkyl analogues of ciprofloxacin. Biomedicine & Pharmacotherapy. 188. 118223–118223.
2.
Chrzanowska, Alicja, et al.. (2024). 1,3-Disubstituted thiourea derivatives: Promising candidates for medicinal applications with enhanced cytotoxic effects on cancer cells. European Journal of Pharmacology. 982. 176885–176885. 2 indexed citations
3.
Chrzanowska, Alicja, et al.. (2023). Proapoptotic effects of halogenated bis‐phenylthiourea derivatives in cancer cells. Archiv der Pharmazie. 356(9). e2300105–e2300105. 4 indexed citations
4.
Chrzanowska, Alicja, Wioletta Olejarz, Grażyna Kubiak-Tomaszewska, Andrzej K. Ciechanowicz, & Marta Struga. (2022). The Effect of Fatty Acids on Ciprofloxacin Cytotoxic Activity in Prostate Cancer Cell Lines—Does Lipid Component Enhance Anticancer Ciprofloxacin Potential?. Cancers. 14(2). 409–409. 10 indexed citations
5.
Drzewiecka‐Antonik, Aleksandra, Marta Struga, Ewa Augustynowicz–Kopeć, et al.. (2022). Synthesis, Structural Characterization and Biological Activity Evaluation of Novel Cu(II) Complexes with 3-(trifluoromethyl)phenylthiourea Derivatives. International Journal of Molecular Sciences. 23(24). 15694–15694. 2 indexed citations
6.
Chrzanowska, Alicja, Marta Struga, Piotr Roszkowski, et al.. (2022). The Effect of Conjugation of Ciprofloxacin and Moxifloxacin with Fatty Acids on Their Antibacterial and Anticancer Activity. International Journal of Molecular Sciences. 23(11). 6261–6261. 14 indexed citations
7.
Chrzanowska, Alicja, et al.. (2022). Anticancer activity and metabolic alteration in colon and prostate cancer cells by novel moxifloxacin conjugates with fatty acids. European Journal of Pharmacology. 940. 175481–175481. 1 indexed citations
8.
Mielczarek‐Puta, Magdalena, et al.. (2021). Teriflunomide – The common drug with underestimated oxygen - Dependent anticancer potential. Biochemistry and Biophysics Reports. 28. 101141–101141. 4 indexed citations
9.
Czopek, Anna, Adam Bucki, Marcin Kołaczkowski, et al.. (2019). Novel multitarget 5-arylidenehydantoins with arylpiperazinealkyl fragment: Pharmacological evaluation and investigation of cytotoxicity and metabolic stability. Bioorganic & Medicinal Chemistry. 27(18). 4163–4173. 9 indexed citations
10.
Szulczyk, Daniel, Anna Bielenica, Ewa Augustynowicz–Kopeć, et al.. (2019). Development of (4-methoxyphenyl)-1H-tetrazol-5-amine regioisomers as a new class of selective antitubercular agents. European Journal of Medicinal Chemistry. 186. 111882–111882. 15 indexed citations
11.
Skrzycki, Michał, et al.. (2015). [The level of superoxide dismutase expression in primary and metastatic colorectal cancer cells in hypoxia and tissue normoxia].. PubMed. 39(233). 281–6. 5 indexed citations
12.
Chrzanowska, Alicja, et al.. (2014). Significance of arginase determination in body fluids of patients with hepatocellular carcinoma and liver cirrhosis before and after surgical treatment. Clinical Biochemistry. 47(12). 1056–1059. 19 indexed citations
13.
Chrzanowska, Alicja, Beata Gajewska, & Anna Barańczyk‐Kuźma. (2009). Arginase isoenzymes in human cirrhotic liver.. Acta Biochimica Polonica. 56(3). 465–9. 13 indexed citations
14.
Mielczarek‐Puta, Magdalena, et al.. (2008). Arginase and arginine in diagnostics of patients with colorectal cancer and patients with colorectal cancer liver metastases. Contemporary Oncology/Współczesna Onkologia. 12(2). 51–55. 4 indexed citations
15.
Mielczarek‐Puta, Magdalena, et al.. (2008). [New insights into arginase. Part II. Role in physiology and pathology].. PubMed. 62. 214–21. 5 indexed citations
16.
Mielczarek‐Puta, Magdalena, Alicja Chrzanowska, & Anna Barańczyk‐Kuźma. (2008). [New insights into arginase. Part I. Structure and characteristics].. PubMed. 62. 206–13. 2 indexed citations
17.
Mielczarek‐Puta, Magdalena, et al.. (2008). l-Arginine as a factor increasing arginase significance in diagnosis of primary and metastatic colorectal cancer. Clinical Biochemistry. 42(4-5). 353–357. 24 indexed citations
18.
Chrzanowska, Alicja, et al.. (2007). [Serum arginase activity in patients with liver cirrhosis and hepatocellular carcinoma].. PubMed. 60(5-6). 215–8. 3 indexed citations
19.
Mielczarek‐Puta, Magdalena, et al.. (2006). Arginase as a Useful Factor for the Diagnosis of Colorectal Cancer Liver Metastases. The International Journal of Biological Markers. 21(1). 40–44. 26 indexed citations
20.
Chrzanowska, Alicja, et al.. (2006). Arginase as a useful factor for the diagnosis of colorectal cancer liver metastases. The International Journal of Biological Markers. 21(1). 40–44. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anil Kumar Badana Breakdown of academic impact, for papers by Lokesh Dalasanur Nagaprashantha Breakdown of academic impact, for papers by Weon Young Chang Breakdown of academic impact, for papers by Sumit J. Shah Breakdown of academic impact, for papers by Caifeng Xie Breakdown of academic impact, for papers by Aamer Qazi Breakdown of academic impact, for papers by Qiangrong Pan Breakdown of academic impact, for papers by Hongqin Zhuang Breakdown of academic impact, for papers by Weiqiang Chen
Rankless by CCL
2026